Reports for TEVA-CANDESARTAN/HCTZ
Brand name
TEVA-CANDESARTAN/HCTZ
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02395568 |
Ingredients
HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL |
Ingredient Strength
12.5 MG 32 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-CANDESARTAN/HCTZ | 30 | Resolved | 2017-03-13 | 2017-10-10 | 974 |
TEVA-CANDESARTAN/HCTZ | 30 PP | Resolved | 2019-11-28 | 2020-04-23 | 99932 |
TEVA-CANDESARTAN/HCTZ | P/P 30 | Resolved | 2020-07-23 | 2020-08-21 | 120878 |
TEVA-CANDESARTAN/HCTZ | 30 | Resolved | 2021-01-28 | 2021-03-04 | 132657 |
TEVA-CANDESARTAN/HCTZ | 30 | Resolved | 2022-10-28 | 2022-12-15 | 173031 |
TEVA-CANDESARTAN/HCTZ | PP | Resolved | 2023-10-05 | 2024-04-05 | 206425 |
Showing 1 to 6 of 6
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0